Cassia Cearley - 06 Mar 2023 Form 4 Insider Report for Icosavax, Inc.

Role
Chief Business Officer
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact for Cassia Cearley
Issuer symbol
N/A
Transactions as of
06 Mar 2023
Net transactions value
-$38,737
Form type
4
Filing time
08 Mar 2023, 16:45:43 UTC
Previous filing
17 Feb 2023
Next filing
25 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Sale $38,737 -5,000 -3.2% $7.75 151,847 06 Mar 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $7.62 and $7.83. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.